Document is current
Any future updates will be listed below
-
Authors
Ismail, Azza https://orcid.org/0000-0002-2295-1785
Nitti, Rosamaria https://orcid.org/0000-0002-7161-6270
Sharrack, Basil
Badoglio, Manuela https://orcid.org/0000-0003-3226-2024
Ambron, Pascale
Labopin, Myriam https://orcid.org/0000-0003-4514-4748
Alexander, Tobias https://orcid.org/0000-0003-1193-0097
Snowden, John A. https://orcid.org/0000-0001-6819-3476
Greco, Raffaella https://orcid.org/0000-0002-6117-5328
- License Information
-
More Information
Article History
Received: 22 February 2024
Revised: 21 July 2024
Accepted: 25 July 2024
First Online: 14 August 2024
Competing interests
: RG discloses speaking honoraria from Biotest, Pfizer, Medac, Neovii and Magenta. TA received study support from Amgen, Janssen and honoraria from Neovii, GSK, Astra-Zeneca, Abbvie. JAS discloses consultancy for Vertex, Medac and Jazz, and advisory board from Kiadis. None of the mentioned conflicts of interest were related to financing of the content of this manuscript. The remaining authors have nothing to declare.
